# Batch 5 Synthetic World-Level File Construction Validation Review

World: Korvin Merrow

Artifact set: Batch 5 Synthetic World-Level Files

Status: CANDIDATE REVIEW

Files reviewed:

- `worlds/korvin-merrow/synthetic-files/candidate-review/batch-5/FI-W22_discharge-facing-plan-snapshot-before-world-close.md`

This validation review checks Batch 5 construction against locked World Spec v1, File Inventory v1, Synthetic World-Level File Construction Plan v1, Governance Package v1, locked Batches 1-4, and the explicit Batch 5 authorization.

It does not create FI-W23, task prompts, expected outputs, golden responses, grader guidance, AutoQC responses, DOCX artifacts, submission artifacts, post-world information, or additional synthetic file rows.

## Authorized File Creation Validation

### VERIFIED

Finding: FI-W22 was created in the authorized Batch 5 candidate-review path.

Evidence: the Batch 5 candidate folder contains FI-W22 and this validation review.

Impact: construction stayed within the authorized Batch 5 file ID.

Action required: none for candidate review.

### VERIFIED

Finding: no unauthorized synthetic world-level file IDs were created.

Evidence: Batch 5 construction stops at FI-W22.

Impact: the locked FI-W01 through FI-W21 files remain the prior canonical world-level sources, and FI-W22 is the only new candidate synthetic file.

Action required: do not create any later or additional synthetic files unless separately authorized.

### VERIFIED

Finding: no task-level, supplementary, prompt, golden, grader, AutoQC, DOCX, submission, or RL Studio artifacts were created.

Evidence: constructed artifacts are limited to FI-W22 and this validation review.

Impact: downstream phase boundaries remain intact.

Action required: none.

## Temporal Validation

### VERIFIED

Finding: FI-W22 remains within the locked world timeline.

Evidence: FI-W22 is anchored on 05/23/2026 before 18:00 and states that no final discharge order has been entered in the snapshot.

Impact: closed-world discipline is preserved.

Action required: none.

### VERIFIED

Finding: no post-world information is present.

Evidence: FI-W22 contains no completed discharge outcome, post-discharge follow-up, +7 follow-up, +30 follow-up, retrospective review, or later task context.

Impact: discharge anchor and later follow-up anchors remain outside the world-level file set.

Action required: preserve this boundary during future task-context construction.

## Trap #5 Validation

### VERIFIED

Finding: FI-W22 implements Trap #5 as a visible but incomplete discharge-facing artifact.

Evidence: FI-W22 presents a readable interdisciplinary discharge-planning snapshot with medical improvement, consultant involvement, functional planning, medication reconciliation, family education, and transition logistics.

Impact: a superficial reviewer could reasonably over-trust FI-W22 because it is visible, organized, and reassuring.

Action required: candidate reviewers should verify it remains useful but insufficient.

### VERIFIED

Finding: FI-W22 does not become a complete answer file.

Evidence: FI-W22 does not finalize disposition, medication restart timing, prednisone taper, consultant disagreement, family concern, therapy recommendation, home service plan, or discharge order.

Impact: safe task performance still requires review of the broader world file set.

Action required: none.

## Trap #3 vs Trap #5 Validation

### VERIFIED

Finding: Trap #3 and Trap #5 remain distinct.

Evidence: FI-W22 acknowledges therapy, nursing, family, and support planning but does not reproduce the detailed nursing, PT, OT, family, or Case Management / Social Work substrate from FI-W17 through FI-W21.

Impact: Trap #3 remains the lower-visibility functional/cognitive evidence problem, while Trap #5 is the over-trust of a visible discharge-facing source.

Action required: do not expand FI-W22 into a complete functional-disposition synthesis during review.

## Consultant Friction Validation

### VERIFIED

Finding: Cardiology vs Nephrology remains unresolved and simultaneously defensible.

Evidence: FI-W22 references the need to preserve cardioprotective therapy while respecting renal recovery and hemodynamic reserve, but it does not choose a final restart sequence or declare either consultant correct.

Impact: Trap #2 and Cardiology vs Nephrology remain active.

Action required: none.

### VERIFIED

Finding: Endocrinology vs Primary Team remains interpretive.

Evidence: FI-W22 includes steroid exposure and the need for clear prednisone instructions without proving adrenal insufficiency, making Endocrinology the answer, or replacing rheumatology provenance.

Impact: Trap #1 and Endocrinology vs Primary Team remain active.

Action required: none.

## Prednisone Hierarchy Validation

### VERIFIED

Finding: prednisone hierarchy is preserved.

Evidence: FI-W22 states that rheumatology provenance remains important for intended outpatient taper context and does not elevate family report, patient recollection, Endocrinology, or the discharge-facing snapshot above rheumatology.

Impact: rheumatology remains the highest outpatient prednisone authority.

Action required: none.

## Family And Functional Evidence Validation

### VERIFIED

Finding: Family vs Primary Team friction remains balanced.

Evidence: FI-W22 describes family involvement and discharge education without making family concern dispositive or making the primary team careless.

Impact: discharge remains plausible but not safely solved.

Action required: none.

### VERIFIED

Finding: FI-W22 does not duplicate the distributed Batch 4 functional/cognitive substrate.

Evidence: FI-W22 summarizes therapy, nursing, assistive-device, supervision, and services as planning items but does not list the detailed cueing, endurance, transfer, medication-management, baseline-deviation, and caregiver-capacity evidence from FI-W17 through FI-W21.

Impact: Batch 4 remains necessary for complete discharge-readiness reasoning.

Action required: none.

## Medication Uncertainty Validation

### VERIFIED

Finding: medication-restart uncertainty is preserved.

Evidence: FI-W22 requires final reconciliation of continued, restarted, held, or deferred medications but does not create a final discharge medication list or restart algorithm.

Impact: FI-W12 trends, FI-W13 MAR/action evidence, Nephrology, Cardiology, Endocrinology, and functional support evidence remain necessary.

Action required: none.

### VERIFIED

Finding: insulin lispro remains inpatient-only.

Evidence: FI-W22 states that inpatient correctional insulin use does not automatically represent a home regimen and does not add insulin lispro to baseline outpatient medications.

Impact: Medication Expansion Package v1 and FI-W13 logic remain intact.

Action required: none.

## Batch Consistency Validation

### VERIFIED

Finding: Batch 1 consistency is preserved.

Evidence: FI-W22 uses Batch 1 provenance only as context: FI-W06 rheumatology remains the intended outpatient prednisone authority, and FI-W07 baseline/family support remains comparator context.

Impact: provenance sources remain separate from the discharge-facing snapshot.

Action required: none.

### VERIFIED

Finding: Batch 2 consistency is preserved.

Evidence: FI-W22 follows FI-W11's medically improving but incomplete discharge-planning frame, uses FI-W12 trend logic without over-resolving, and respects FI-W13 as an inpatient action source rather than a final medication plan.

Impact: hospital-course spine remains intact.

Action required: none.

### VERIFIED

Finding: Batch 3 consistency is preserved.

Evidence: FI-W22 acknowledges Nephrology, Cardiology, and Endocrinology involvement without reproducing all caveats, choosing the correct consultant, or converting consultant notes into final authority.

Impact: consultants remain interpretation sources.

Action required: none.

### VERIFIED

Finding: Batch 4 consistency is preserved.

Evidence: FI-W22 references functional and support planning without resolving the nursing, PT, OT, family, and Case Management / Social Work evidence.

Impact: distributed functional and transition evidence remains necessary.

Action required: none.

## Answer-File Drift Validation

### VERIFIED

Finding: FI-W22 is not a final disposition answer.

Evidence: FI-W22 states that no final discharge order has been entered and that final disposition depends on medication reconciliation, functional recommendations, education completion, support confirmation, and attending review.

Impact: discharge readiness remains a synthesis task.

Action required: none.

### VERIFIED

Finding: FI-W22 is not a final medication, steroid, consultant, or functional answer.

Evidence: FI-W22 preserves open final reconciliation, prednisone instruction, consultant-timing, family-support, therapy, and services items.

Impact: world review remains required.

Action required: none.

## Carry-Forward Watch Items

- Candidate review must test whether FI-W22 is too complete or too explicitly caveated.
- FI-W22 must remain visible, useful, and reassuring but insufficient if trusted alone.
- FI-W22 must not resolve final disposition, medication restart timing, prednisone history, consultant disagreement, family concern, functional support level, or service sufficiency.
- Future task files must not turn FI-W22 into the source-of-truth answer.
- Future task prompts, expected outputs, goldens, and grader guidance remain blocked until explicitly authorized and must preserve physician-perspective task-design guidance.

## Final Validation Status

Batch 5 Synthetic World-Level File Construction:

- FI-W22 created.
- Status: CANDIDATE REVIEW.
- No unauthorized files created.
- No temporal leakage identified.
- Trap #5 preserved.
- Trap #3 vs Trap #5 distinction preserved.
- Cardiology vs Nephrology friction preserved.
- Endocrinology vs Primary Team friction preserved.
- Family vs Primary Team friction preserved.
- Prednisone hierarchy preserved.
- Batch 1, Batch 2, Batch 3, and Batch 4 consistency preserved.
- No answer-file drift identified.
